Dividend stocks are one of the most effective long-term strategies. Accordingly, we have chose the top 3 dividend stocks for ...

Biodexa Pharmaceuticals PLC ("Biodexa” or the "Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

Despite Pfizer management's cost-cutting and a large drug pipeline, revenue growth remains uncertain. Click here to read an ...

PFE stock offers high dividend yields supported by cost optimizations and R&D. Discover its potential amid COVID-19 sales ...

Dividend stocks are a smart way to navigate an uncertain market. Besides generating steady passive income, dividend-paying ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

Although it appears not to cause more severe illness, preliminary data demonstrate that the variant exhibits significant ...

Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.